Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?

doi:10.3748/wjg.v30.i10.1368

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1093)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

WORD

HTML

525

Figures (1-1)

Tables (1-5)

Sum=702

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

121

Download

Sum=217

Publishing Process of This Article

Item

Count

Browse

Download

Sum=132

Mar 14, 2024 (publication date) through May 10, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Mar 14, 2024; 30(10): 1368-1376
Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1368

Table 3 Stage distribution of colorectal cancer by diagnostic route in two hospitals, n (%)

Tumor stage	Follow-up group (n = 715)	Symptomatic group (n = 1064)	Cancer screening group (n = 304)
Stage 0	216 (30.2)	92 (8.7)	81 (26.6)
Stage I	194 (27.1)	162 (15.2)	100 (32.9)
Stage II	106 (14.8)	240 (22.6)	39 (12.8)
Stage III	109 (15.2)	297 (27.9)	54 (17.8)
Stage IV	90 (12.6)	273 (25.7)	30 (9.9)
Early-stage	410 (57.3)	254 (23.9)	181 (59.5)

Follow-up group: Patients with cancer detected during follow-up for other comorbidities; symptomatic group: Patients with complaints associated with colorectal cancer-related symptoms; cancer screening group: Patients detected by screening or medical check-up. Early stages: 0 and I.

Citation: Agatsuma N, Utsumi T, Nishikawa Y, Horimatsu T, Seta T, Yamashita Y, Tanaka Y, Inoue T, Nakanishi Y, Shimizu T, Ohno M, Fukushima A, Nakayama T, Seno H. Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened? World J Gastroenterol 2024; 30(10): 1368-1376
URL: https://www.wjgnet.com/1007-9327/full/v30/i10/1368.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i10.1368